These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29588074)

  • 21. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
    Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
    Noize P; Bazin F; Dufouil C; Lechevallier-Michel N; Ancelin ML; Dartigues JF; Tzourio C; Moore N; Fourrier-Réglat A
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):310-9. PubMed ID: 19241438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the French National Health Insurance Information System as a tool for epidemiological surveillance of malaria.
    Delon F; Mayet A; Thellier M; Kendjo E; Michel R; Ollivier L; Chatellier G; Desjeux G
    J Am Med Inform Assoc; 2017 May; 24(3):588-595. PubMed ID: 28040684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.
    Paterson JM; Laupacis A; Bassett K; Anderson GM;
    Health Aff (Millwood); 2006; 25(5):1436-43. PubMed ID: 16966744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homeopathy in France in 2011-2012 according to reimbursements in the French national health insurance database (SNIIRAM).
    Piolot M; Fagot JP; Rivière S; Fagot-Campagna A; Debeugny G; Couzigou P; Alla F
    Fam Pract; 2015 Aug; 32(4):442-8. PubMed ID: 25921648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A visual approach of care pathways from the French nationwide SNDS database - from population to individual records: the ePEPS toolbox.
    Happe A; Drezen E
    Fundam Clin Pharmacol; 2018 Feb; 32(1):81-84. PubMed ID: 28921707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Health status of populations living in French overseas territories in 2012, compared with metropolitan France: An analysis of the national health insurance database].
    Filipovic-Pierucci A; Rigault A; Fagot-Campagna A; Tuppin P
    Rev Epidemiol Sante Publique; 2016 Jun; 64(3):175-83. PubMed ID: 27238162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacoepidemiology. Analysis of drug prescription data].
    Gothe H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1145-54. PubMed ID: 18985408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems.
    Bailly L; David R; Chevrier R; Grebet J; Moncada M; Fuch A; Sciortino V; Robert P; Pradier C
    PLoS One; 2019; 14(5):e0216221. PubMed ID: 31059547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. French health insurance databases: What interest for medical research?
    Moulis G; Lapeyre-Mestre M; Palmaro A; Pugnet G; Montastruc JL; Sailler L
    Rev Med Interne; 2015 Jun; 36(6):411-7. PubMed ID: 25547954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare databases in Europe for studying medicine use and safety during pregnancy.
    Charlton RA; Neville AJ; Jordan S; Pierini A; Damase-Michel C; Klungsøyr K; Andersen AM; Hansen AV; Gini R; Bos JH; Puccini A; Hurault-Delarue C; Brooks CJ; de Jong-van den Berg LT; de Vries CS
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):586-94. PubMed ID: 24664855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of algorithms to identify incident cancer cases by using French health administrative databases.
    Ajrouche A; Estellat C; De Rycke Y; Tubach F
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):935-944. PubMed ID: 28485129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From medico-administrative databases analysis to care trajectories analytics: an example with the French SNDS.
    Drezen E; Guyet T; Happe A
    Fundam Clin Pharmacol; 2018 Feb; 32(1):78-80. PubMed ID: 28921732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of administrative health databases in infectious disease epidemiology and public health].
    Fonteneau L; Le Meur N; Cohen-Akenine A; Pessel C; Brouard C; Delon F; Desjeux G; Durand J; Kirchgesner J; Lapidus N; Lemaitre M; Tala S; Thiébaut A; Watier L; Rudant J; Guillon-Grammatico L
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S174-S182. PubMed ID: 28624133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Using cancer case identification algorithms in medico-administrative databases: Literature review and first results from the REDSIAM Tumors group based on breast, colon, and lung cancer].
    Bousquet PJ; Caillet P; Coeuret-Pellicer M; Goulard H; Kudjawu YC; Le Bihan C; Lecuyer AI; Séguret F
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S236-S242. PubMed ID: 28576379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study.
    Bosco-Lévy P; de Boissieu P; Gouverneur A; Noize P; Molimard M; Fourrier-Réglat A; Bezin J
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1233-1241. PubMed ID: 28771878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.
    Luo X; Doherty J; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 Nov; 23(11):2607-15. PubMed ID: 17854515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Public health research with statutory health insurance drug data].
    Janhsen K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):521-5. PubMed ID: 15221100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example.
    Rawson NS
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1072-9. PubMed ID: 19650154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacoepidemiology in pediatrics: Needs, challenges and future directions for research.
    Osokogu OU; Verhamme K; Sturkenboom M; Kaguelidou F
    Therapie; 2018 Apr; 73(2):151-156. PubMed ID: 29580613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.